Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress

Pulmonary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2014, Pages 150-155

  Zhang, Hong Xia ^a,b   Duan, Guo Li ^c   Wang, Chang Nan ^a   Zhang, Yun Qian ^a   Zhu, Xiao Yan ^a   Liu, Yu Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Laboratory Medicine   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxemia; Lung; Nitrative stress; Oxidative stress; Resveratrol

Indexed keywords

3 NITROTYROSINE; CATALASE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NITRIC OXIDE; PEROXYNITRITE; RESVERATROL; SUPEROXIDE DISMUTASE; ANTIOXIDANT; PEROXYNITROUS ACID; STILBENE DERIVATIVE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG PARENCHYMA; MALE; MOUSE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ACUTE LUNG INJURY; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEROXYNITROUS ACID; STILBENES; SUPEROXIDE DISMUTASE;

EID: 84895928381     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.07.007     Document Type: Article

References (49)

1. Weinacker A.B., Vaszar L.T. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 2001, 52:221-237.
2. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. NEngl J Med 2005, 353:1685-1693.
3. Matthay M.A., Ware L.B., Zimmerman G.A. The acute respiratory distress syndrome. JClin Invest 2012, 122:2731-2740.
4. Shafeeq H., Lat I. Pharmacotherapy for acute respiratory distress syndrome. Pharmacotherapy 2012, 32:943-957.
5. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011, 6:147-163.
6. Crimi E., Slutsky A.S. Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol 2004, 18:477-492.
7. Zhou X., Dai Q., Huang X. Neutrophils in acute lung injury. Front Biosci 2012, 17:2278-2283.
8. Yamashita C.M., Lewis J.F. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs 2012, 17:1-4.
9. The ARDS Clinical Trials Network, National Heart, Lung, and Blood Institute, National Institutes of Health Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002, 30:1-6.
10. The ARDS Network Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAm Med Assoc 2000, 283:1995-2002.
11. Ward P.A. Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 2010, 1203:53-59.
12. Guo R.F., Ward P.A. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 2007, 9:1991-2002.
13. Roberts R.A., Laskin D.L., Smith C.V., Robertson F.M., Allen E.M., Doorn J.A., et al. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009, 112:4-16.
14. Janssen-Heininger Y.M., Persinger R.L., Korn S.H., Pantano C., McElhinney B., Reynaert N.L., et al. Reactive nitrogen species and cell signaling: implications for death or survival of lung epithelium. Am J Respir Crit Care Med 2002, 166:S9-S16.
15. Traber D.L., Hawkins H.K., Enkhbaatar P., Cox R.A., Schmalstieg F.C., Zwischenberger J.B., et al. The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation. Pulm Pharmacol Ther 2007, 20:163-166.
16. Chung J.H., Manganiello V., Dyck J.R. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol 2012, 22:546-554.
17. Ma L., Zhao Y., Li B., Wang Q., Liu X., Chen X., et al. 3,5,4'-Tri-O-acetylresveratrol attenuates seawater aspiration-induced lung injury by inhibiting activation of nuclear factor-kappa B and hypoxia-inducible factor-1α. Respir Physiol Neurobiol 2013, 185:608-614.
18. Rieder S.A., Nagarkatti P., Nagarkatti M. Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury. Br J Pharmacol 2012, 167:1244-1258.
19. Lu C.C., Lai H.C., Hsieh S.C., Chen J.K. Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats. JLeukoc Biol 2008, 83:1028-1037.
20. Venet F., Huang X., Chung C.S., Chen Y., Ayala A. Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am J Pathol 2010, 176:764-773.
21. Sener G., Topaloǧlu N., Sehirli A.O., Ercan F., Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007, 20:642-649.
22. Yang T., Zhang J., Sun L., Zhu X., Li J., Wang J., et al. Combined effects of a neutrophil elastase inhibitor (sivelestat sodium) and a free radical scavenger (edaravone) on lipopolysaccharide-induced acute lung injury in rats. Inflamm Res 2012, 61:563-569.
23. Tanino Y., Makita H., Miyamoto K., Betsuyaku T., Ohtsuka Y., Nishihira J., et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 283:L156-L162.
24. Wang S., Zhu X., Cong B., You X., Wang Y., Wang W., et al. Estrogenic action on arterial smooth muscle: permissive for maintenance of CRHR2 expression. Endocrinology 2012, 153:1915-1924.
25. Fu Z., Liu X., Geng B., Fang L., Tang C. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008, 82:1196-1202.
26. Zhu X.Y., Liu S.J., Liu Y.J., Wang S., Ni X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages. Cell Mol Life Sci 2010, 67:1119-1132.
27. Ji L., Fu F., Zhang L., Liu W., Cai X., Zhang L., et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010, 298:E871-E880.
28. Wiesel P., Patel A.P., DiFonzo N., Marria P.B., Sim C.U., Pellacani A., et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 2000, 102:3015-3022.
29. Liu Y.C., Chang A.Y., Tsai Y.C., Chan J.Y. Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. JBiomed Sci 2009, 16:8.
30. Jones D.P. Redefining oxidative stress. Antioxid Redox Signal 2006, 8:1865-1879.
31. Baron R.M., Carvajal I.M., Liu X., Okabe R.O., Fredenburgh L.E., Macias A.A. Reduction of nitric oxide synthase 2 expression by distamycin A improves survival from endotoxemia. JImmunol 2004, 173:4147-4153.
32. Farley K.S., Wang L.F., Razavi H.M., Law C., Rohan M., McCormack D.G., et al. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1164-L1172.
33. van der Vliet A., Cross C.E. Oxidants, nitrosants, and the lung. Am J Med 2000, 109:398-421.
34. Crapo J.D. Redox active agents in inflammatory lung injury. Am J Respir Crit Care Med 2003, 168:1027-1028.
35. Wang J., He D., Zhang Q., Han Y., Jin S., Qi F. Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 2009, 24:675-680.
36. Wood L.G., Wark P.A., Garg M.L. Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 2010, 13:1535-1548.
37. Bradamante S., Barenghi L., Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004, 22:169-188.
38. Spanier G., Xu H., Xia N., Tobias S., Deng S., Wojnowski L., et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). JPhysiol Pharmacol 2009, 60:111-116.
39. Zhang H., Shih A., Rinna A., Forman H.J. Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells. Arch Biochem Biophys 2009, 481:110-115.
40. Kode A., Rajendrasozhan S., Caito S., Yang S.R., Megson I.L., Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008, 294:L478-L488.
41. D'Alessio F.R., Tsushima K., Aggarwal N.R., Mock J.R., Eto Y., Garibaldi B.T., et al. Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. JImmunol 2012, 189:2234-2245.
42. Okamoto T., Gohil K., Finkelstein E.I., Bove P., Akaike T., van der Vliet A. Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004, 286:L198-L209.
43. Csiszar A., Labinskyy N., Olson S., Pinto J.T., Gupte S., Wu J.M., et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009, 54:668-675.
44. Wung B.S., Hsu M.C., Wu C.C., Hsieh C.W. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci 2005, 78:389-397.
45. Abdallah D.M., Ismael N.R. Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats. Can J Physiol Pharmacol 2011, 89:811-818.
46. Cignarella A., Minici C., Bolego C., Pinna C., Sanvito P., Gaion R.M., et al. Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr Metab Cardiovasc Dis 2006, 16:322-329.
47. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004, 287:L774-L783.
48. Leiro J., Alvarez E., Arranz J.A., Laguna R., Uriarte E., Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. JLeukoc Biol 2004, 75:1156-1165.
49. Zhu X., Liu Q., Wang M., Liang M., Yang X., Xu X., et al. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One 2011, 6:e27081.